Data / Form D filings / Manifold Biotechnologies, Inc.
Manifold Biotechnologies, Inc.: Form D filings
Manifold Biotechnologies, Inc., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2020 and 2024. The latest, on December 3, 2024, reports $32.8 million sold of a $32.8 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 201 BROOKLINE AVENUE, SUITE 902, Boston, MA, 02215
- Phone
- (801) 244-4494
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1820326
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 3, 2024 | New notice | $32,784,801 | $32,784,801 | 10 | Nov 18, 2024 | sec.gov | |
| Jun 13, 2022 | New notice | $39,999,985 | $39,999,985 | 13 | May 27, 2022 | sec.gov | |
| Aug 13, 2020 | New notice | $5,400,694 | $5,400,694 | 6 | Jul 29, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jory Bell | Director | |
| Gleb Kuznetsov | Executive Officer, Director | |
| Jeff Huber | Director | |
| Pierce Ogden | Executive Officer, Director | |
| Steven J. Kafka | Director | |
| Steven Holtzman | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 2, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Manifold Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.